健脾益肾生血法疗肾性贫血的疗效观察 及延缓病程的临床意义.pdfVIP

成都中医药大学硕士论文 Abstract Objective: To evaluate the clinical efficacy JianpiYishenShengxueFa with rHuEPO(recombinant human erythropoietin) in the treatment of Chronic renal anemia and to provide theoretical basis for Chinese medicine treatment of renal anemia. Methods: Collect 62 cases of patients to conform to the RA research standard, were randomly divided into control group and treatment group, each group had 31 patients. The control group was given rHuEPO, iron, folic acid treatment and the treatment group was treated rHuEPO, iron, and folic acid with JianpiYishenShengxue tang. Two groups were treated for 8 weeks, 4 weeks for a course of treatment.Before and aftertreatment, observed the changes in patient, s hemoglobin 、red bloodcell 、 hematocrit, reticulocyte count, serum creatinine, blood urea nitrogen, and clinical symptoms and symptom scores. Statistical analysis：data processing using SPSS17.0 statistical analysis software ．P 0.05 was significantly different; P 0.01 as significant difference; P 0.05 for no significant difference. Results: 1.The clinical efficacy: the control group, the total effective rate was 70.97%, , the treatment group s total effective rate was 87.10%,treatment group was better than the control group(P 0.05).2. To correct anemia ，treatment group was faster than the control group: After 2weeks of treatment, RBC, Hb, HCT were significantly improved o f t h e t r e a t m e n t g r o u p , ( P 0 . 0 5 ) . A t t h e s a m e t i m e , t h e c h a n g e of the control group was not statistically significant (P 0.05).After 8 weeks, there were significantly different between the two groups (P 0.05 or P 0.01). After 2 weeks, both groups